About AGEMICA, INC.
AGEMICA is an AI-native biotech company focused on advancing healthy longevity by addressing aging, cancer, and disease through AI-driven drug discovery and vaccine design.
AI Predict safe repurposed drug combinations from disease omicsAI Design peptide and mRNA vaccines for cancer and aging targetsTrack ex-vivo cancer response and healthy-cell selectivityRank disease mechanisms across omics data, targets, and safe-drug librariesEvaluate ranked combinations in ex-vivo human cancer modelsMeasure cancer-cell death, tumor-volume reduction, and healthy-cell safetyAdvance the strongest ex-vivo candidates toward humanized-mouse studies, IND-enabling work, and future clinical development
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to AGEMICA, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.